Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disease, Amyotrophic Lateral Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06315608
What this trial is testing

MRG-001 in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral SclerosisLou Gehrig DiseaseMotor Neuron Disease+1 more
MedRegen LLC 10
Not applicableActive Not RecruitingNCT03362658
What this trial is testing

Novel MRI Biomarkers for Monitoring Disease Progression in ALS

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
University of Alberta 119
Not applicableNot Yet RecruitingNCT07479017
What this trial is testing

Characterization of Platelet Molecular Profiles in ALS for the Identification of Specific Diagnostic Biomarkers - A Pilot Study

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
University Hospital, Tours 60
Not applicableStudy completedNCT01592552
What this trial is testing

A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery

Who this might be right for
Alzheimer's DiseaseMultiple SclerosisParkinson's Disease+2 more
Sanguine Biosciences 20
Not applicableUnknownNCT03285204
What this trial is testing

Relationship Between Neurological Disability and Visual Impairment in Patients With ALS or Friedreich's Ataxia

Who this might be right for
Amyotrophic Lateral Sclerosis
Jose Luis Urcelay Segura 90
Not applicableStudy completedNCT03579017
What this trial is testing

Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Validation Study

Who this might be right for
Amyotrophic Lateral SclerosisCognitive Impairment
Haukeland University Hospital 31
Very early researchLooking for participantsNCT06891716
What this trial is testing

[18F]ACI-19626 PET in TDP-43 Proteinopathies

Who this might be right for
Frontotemporal Dementia (FTD)Amyotrophic Lateral Sclerosis (ALS)TDP-43 Proteinopathies+2 more
AC Immune SA 45
Early research (Phase 1)Looking for participantsNCT06556394
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RAG-17 in Subjects With Amyotrophic Lateral Sclerosis (ALS) With Superoxide Dismutase Type 1 (SOD1) Gene Mutation

Who this might be right for
Amyotrophic Lateral Sclerosis
Ractigen Therapeutics. 32
Not applicableNot Yet RecruitingNCT07737977
What this trial is testing

Developing a Comprehensive Biomarker Panel for Monitoring Progression and Early Detection in ALS Patients

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
University Hospital, Montpellier 200
Large-scale testing (Phase 3)Study completedNCT00868166
What this trial is testing

Safety and Efficacy of TRO19622 as add-on Therapy to Riluzole Versus Placebo in Treatment of Patients Suffering From ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Hoffmann-La Roche 512
Not applicableStudy completedNCT00023075
What this trial is testing

Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis

Who this might be right for
Primary Lateral SclerosisHereditary Spastic ParaplegiaAmyotrophic Lateral Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 55
Testing effectiveness (Phase 2)Study completedNCT03481348
What this trial is testing

Pharyngeal Electrical Stimulation in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Ulm 20
Not applicableLooking for participantsNCT05116943
What this trial is testing

Biospecimen Biorepository for the Study of ALS, ALS-FTD and Similar Neurodegenerative Disorders

Who this might be right for
Amyotrophic Lateral Sclerosis
Mayo Clinic 100
Testing effectiveness (Phase 2)Study completedNCT03472950
What this trial is testing

Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral Sclerosis

Who this might be right for
ALS
University of Kansas Medical Center 14
Not applicableStudy completedNCT01090674
What this trial is testing

Relationship Between Respiratory Functional Tests and Image Thoracic Techniques in Patients With Neuromuscular Diseases

Who this might be right for
Amyotrophic Lateral Sclerosis
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 5
Not applicableStudy completedNCT02852278
What this trial is testing

A Patient Centric Motor Neuron Disease Activities of Daily Living Scale

Who this might be right for
Amyotrophic Lateral SclerosisProgressive Muscular AtrophyPrimary Lateral Sclerosis+1 more
University of South Florida 410
Testing effectiveness (Phase 2)Active Not RecruitingNCT05407324
What this trial is testing

Dazucorilant in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Corcept Therapeutics 279
Post-approval studies (Phase 4)Active Not RecruitingNCT07223723
What this trial is testing

Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese Participants With SOD-1 Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Biogen 12
Testing effectiveness (Phase 2)Study completedNCT02290886
What this trial is testing

Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis Lateral

Who this might be right for
Amyotrophic Lateral Sclerosis
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud 52
Large-scale testing (Phase 3)Study completedNCT00444613
What this trial is testing

A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Eisai Co., Ltd. 373
Next Page